Blood eosinophils and exhaled nitric oxide: surrogate biomarkers of airway eosinophilia in stable copd and exacerbation

HIGHLIGHTS

• who: Balazs Antus and Imre Barta from the Department of Pathophysiology, National Koranyi Institute of Pulmology, Koranyi Frigyes Ut , have published the research work: Blood Eosinophils and Exhaled Nitric Oxide: Surrogate Biomarkers of Airway Eosinophilia in Stable COPD and Exacerbation, in the Journal: Biomedicines 2022, 10, 2128. of /2022/
• what: COPD is a chronic respiratory disease characterized by persistent respiratory symptoms, impaired quality of life, chronic airway inflammation, and, in most cases, a progressive decline in lung function.
• how: In this review the authors will focus on two established biomarkers fractional exhaled nitric . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.